January 01, 1992; 42 (1) Articles
Serial gadolinium‐enhanced MRI in relapsing/remitting multiple sclerosis of varying disease duration
A. J. Thompson, D. Miller, B. Youl, D. MacManus, S. Moore, D. Kingsley, B. Kendall, A. Feinstein, W. I. McDonald
First published January 1, 1992, DOI: https://doi.org/10.1212/WNL.42.1.60
A. J. Thompson
D. Miller
B. Youl
D. MacManus
S. Moore
D. Kingsley
B. Kendall
A. Feinstein
Serial gadolinium‐enhanced MRI in relapsing/remitting multiple sclerosis of varying disease duration
A. J. Thompson, D. Miller, B. Youl, D. MacManus, S. Moore, D. Kingsley, B. Kendall, A. Feinstein, W. I. McDonald
Neurology Jan 1992, 42 (1) 60; DOI: 10.1212/WNL.42.1.60
Citation Manager Formats
Make Comment
See Comments

Abstract
In the planning of MRI protocols to monitor disease activity in multiple sclerosis (MS), the clinical subtype needs to be considered. In this serial gadolinium-enhanced MRI study, we demonstrated differences between patients with early relapsing/remitting MS and benign MS in both the production of new lesions and the occurrence of enhancement.
- © 1992 by Edgell Communications, Inc.
Disputes & Debates: Rapid online correspondence
No comments have been published for this article.
NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.
- Stay timely. Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- 200 words maximum.
- 5 references maximum. Reference 1 must be the article on which you are commenting.
- 5 authors maximum. Exception: replies can include all original authors of the article.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Advertisement
Related Articles
- No related articles found.